Related Experiment Video
Updated: Aug 26, 2026

Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses
Published on: June 8, 2022
PKC activates BKCa channels in rat pulmonary arterial smooth muscle via cGMP-dependent protein kinase
Scott A Barman1, Shu Zhu, Richard E White
1Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912, USA. sbarman@mail.mcg.edu
Abstract:
Normally, signaling mechanisms that activate large-conductance, calcium- and voltage-activated potassium (BK(Ca)) channels in pulmonary vascular smooth muscle cause pulmonary vasodilatation. BK(Ca)-channel modulation is important in the regulation of pulmonary arterial pressure, and inhibition (decrease in the opening probability) of the BK(Ca) channel has been implicated in the development of pulmonary vasoconstriction. Protein kinase C (PKC) causes pulmonary vasoconstriction, but little is known about the effect of PKC on BK(Ca)-channel activity in pulmonary vascular smooth muscle. Accordingly, studies were done to determine the effect of PKC on BK(Ca)-channel activity using patch-clamp studies in pulmonary arterial smooth muscle cells (PASMCs) of the Sprague-Dawley rat. The PKC activators phorbol myristate acetate (PMA) and thymeleatoxin opened BK(Ca) channels in single Sprague-Dawley rat PASMC. The activator response to both PMA and thymeleatoxin on BK(Ca)-channel activity was blocked by Gö-6983, which selectively blocks PKC-alpha, -delta, -gamma, and -zeta, and by rottlerin, which selectively inhibits PKC-delta. In addition, the specific cyclic GMP-dependent protein kinase antagonist KT-5823 blocked the responses to PMA and thymelatoxin, whereas the specific cyclic AMP-dependent protein kinase blocker KT-5720 had no effect. In isolated pulmonary arterial vessels, both PMA and forskolin caused vasodilatation, which was inhibited by KT-5823, Gö-6983, or the BK(Ca)-channel blocker tetraethylammonium. The results of this study indicate that activation of specific PKC isozymes increases BK(Ca)-channel activity in Sprague-Dawley rat PASMC via cyclic GMP-dependent protein kinase, which suggests a unique signaling mechanism for vasodilatation.
Insights
Protein kinase C (PKC) activation in rat pulmonary arteries increases large-conductance, calcium- and voltage-activated potassium (BK(Ca)) channel activity. This pathway, mediated by cyclic GMP-dependent protein kinase, promotes pulmonary vasodilatation.
Area of Science:
- Physiology
- Molecular Biology
- Pharmacology
Background:
- Large-conductance, calcium- and voltage-activated potassium (BK(Ca)) channels regulate pulmonary vascular tone.
- Inhibition of BK(Ca) channels is linked to pulmonary vasoconstriction.
- Protein kinase C (PKC) is known to cause pulmonary vasoconstriction, but its effect on BK(Ca) channels in pulmonary vasculature is unclear.
Purpose of the Study:
- To investigate the effect of PKC on BK(Ca)-channel activity in pulmonary arterial smooth muscle cells (PASMCs).
- To elucidate the signaling pathway involved in PKC-mediated BK(Ca)-channel modulation in pulmonary vasculature.
Main Methods:
- Patch-clamp electrophysiology was used to study BK(Ca)-channel activity in rat PASMCs.
- PKC activators (phorbol myristate acetate, thymeleatoxin) and inhibitors (Gö-6983, rottlerin) were employed.
- Specific protein kinase antagonists (KT-5823 for cGMP-dependent kinase, KT-5720 for cAMP-dependent kinase) were used.
- Vasodilatation was assessed in isolated pulmonary arterial vessels.
Main Results:
- PKC activators (PMA, thymeleatoxin) increased BK(Ca)-channel activity in PASMCs.
- The effects of PMA and thymeleatoxin were blocked by PKC inhibitors (Gö-6983, rottlerin).
- The response to PKC activation was inhibited by a cGMP-dependent protein kinase antagonist (KT-5823) but not by a cAMP-dependent protein kinase antagonist (KT-5720).
- In isolated vessels, PMA and forskolin induced vasodilatation, which was attenuated by KT-5823, Gö-6983, or a BK(Ca)-channel blocker (tetraethylammonium).
Conclusions:
- Specific PKC isozymes activate BK(Ca) channels in rat PASMCs.
- This activation occurs via a pathway involving cyclic GMP-dependent protein kinase.
- This represents a novel signaling mechanism contributing to pulmonary vasodilatation.
More Related Videos
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Two...
G-Protein Gated Ion Channels
Sensory organs,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Nitric Oxide Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...